CN106511447A - 一种细胞障碍修复营养补充方法及其药物配方 - Google Patents

一种细胞障碍修复营养补充方法及其药物配方 Download PDF

Info

Publication number
CN106511447A
CN106511447A CN201610975823.5A CN201610975823A CN106511447A CN 106511447 A CN106511447 A CN 106511447A CN 201610975823 A CN201610975823 A CN 201610975823A CN 106511447 A CN106511447 A CN 106511447A
Authority
CN
China
Prior art keywords
vitamin
medicament
inosine
parts
kinds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610975823.5A
Other languages
English (en)
Inventor
肖远
肖刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610975823.5A priority Critical patent/CN106511447A/zh
Publication of CN106511447A publication Critical patent/CN106511447A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Insects & Arthropods (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

本发明涉及一种细胞障碍修复营养补充方法及其药物配方。细胞是人体组织结构的基础，其代谢功能正常，人体组织的结构及功能就正常，人体就健康，如按配方及用法预防疾病，就能获得满意的效果。因此，通过最合理的药物配比以及通过对摄入时间用量能有效的从细胞代谢这一根源有效预防和治疗亚健康、亚临床，预防和治疗大多数急慢性病。

Description

一种细胞障碍修复营养补充方法及其药物配方
技术领域
本发明涉及一种细胞障碍修复营养补充方法及其药物配方，属于细胞修复药物技术领域。
背景技术
随着生活质量的提升，生活节奏的加快，目前亚健康、亚临床人群增加，各种慢性病呈“井喷”现象之流，主流医药缺乏更好的预防和治疗手段。目前，在现有技术中治亚健康的药物很多，这些药物一般都有一定的疗效作用，但大多数药存在着价格较高、起效慢、疗程较长的问题，而且有些药还存在着有一定的毒副作用。
而上述人群及慢性病增多的现象，病因复杂，预防及治疗手段繁多，方式方法多种，在预防疾病中起了一定的作用，但从未细胞代谢这一根本问题上考虑。
发明内容
本发明的目的是：提供一种从细胞代谢这一根本问题着手，通过细胞障碍修复方法预防和治疗亚健康、亚临床的细胞障碍修复营养补充方法及其药物配方。
雷蒙德.佛朗西斯，美国麻省理工大学毕业的化学家。他在《选择健康》一书中提出的“只有一种疾病”的理论被称为过去的200多年中最重要的医学发现。人体由细胞组成，当细胞除了故障，人的身体就不能继续维持生态平衡来调节和维护自己的正常机能。不管你如何去给疾病命名或研究它来龙去脉，细胞故障都是疾病的根源。
导致疾病只有两种原因：营养不良与毒素侵袭。
要维持良好的健康，你需要做的就是保证提供细胞所必要的营养以及保护细胞避免吸入他们不需要的毒素。
作为一种细胞障碍修复的营养补充方法及配方，充分考虑到细胞代谢这一根本问题。细胞是人体组织结构的基础，其代谢功能正常，人体组织的结构及功能就正常，人体就健康，如按配方及用法预防疾病，就能获得满意的效果。
本发明是这样实现的：它主要由肌苷、维他命C、维生素复合B、辅酶Q10、乐力钙、善存银片、硫辛酸、维生素E、维生素AD、叶酸、蜂胶、黄芪、甘草共13种药剂混合包装成小袋即可。根据治疗不同阶段所需药剂有所不同，整个一个疗程分为三个阶段，使用三种不同配比的药剂，三种药剂分别命名为药剂A、药剂B、药剂C。
药剂A主要由肌苷、维他命C、维生素复合B、辅酶Q10、乐力钙、善存银片、硫辛酸、维生素E、维生素AD、叶酸、蜂胶、黄芪、甘草共13种药剂混合包装成小袋即可。
药剂A的各味原材料按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份；乐力钙：7.61份；善存银片：3.44份；硫辛酸：2.29份；维生素E：0.76份；维生素AD：0.61份；叶酸：0.03份；蜂胶：3.59份；黄芪：22.94份；甘草：22.94份。
本发明药物其制法为：将肌苷、维他命C、维生素复合B、辅酶Q10、乐力钙、善存银片、硫辛酸、维生素E、维生素AD、叶酸、蜂胶、黄芪、甘草混合包装成小袋。
药剂B主要由肌苷、维他命C、维生素复合B、辅酶Q10共4种药剂混合包装成小袋即可。
药剂B的各味原材料按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份。
本发明药物其制法为：将肌苷、维他命C、维生素复合B、辅酶Q10混合包装成小袋。
药剂C主要由肌苷、维他命C、维生素复合B共3种药剂混合包装成小袋即可。
药剂C的各味原材料按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份。
具体实施方式
将肌苷、维他命C、维生素复合B、辅酶Q10、乐力钙、善存银片、硫辛酸、维生素E、维生素AD、叶酸、蜂胶、黄芪、甘草共13种药剂按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份；乐力钙：7.61份；善存银片：3.44份；硫辛酸：2.29份；维生素E：0.76份；维生素AD：0.61份；叶酸：0.03份；蜂胶：3.59份；黄芪：22.94份；甘草：22.94份，混合包装成小袋制成药剂A。
将肌苷、维他命C、维生素复合B、辅酶Q10共4种药剂按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份，混合包装成小袋制成药剂B。
将肌苷、维他命C、维生素复合B共3种药剂按重量分配比分别为肌苷4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份，混合包装成小袋制成药剂C。
用法：
以30天为一个治疗疗程。
第1天到第10天，每天早上服用一袋药剂A，晚上服用一袋药剂B。
第11天到第20天，每天早晚各三袋药剂C。
第21天至30天，不吃药。
注意事项：服用药剂A应随肉或蛋黄一起服用或服用前先食用一定量肉或蛋。
【适用人群】亚健康或亚临床人群。
临床案例报告
临床资料：本组病人是门诊诊治的10例(病症)病人为治疗组，没有做对照组临床。治疗组病人10例，其中男5例，女5例；年龄最大60岁，最小者25岁，平均年龄42.5岁，治疗时间六个月。
诊断标准：以患者自诉诊断为诊断标准。
治疗标准：以患者自诉感觉诊断为治疗标准。
临床控制：显效：缓解不适，以及各种急慢性病得到改善；无效：治疗后未见任何效果为无效。
治疗结果：显效：10例；无效：0例；总有效率100％。
治疗时间一个月，各类不适明显缓解，失眠患者睡眠质量得到显著提高，更年期综合症的潮热多汗也得到显著缓解；
治疗时间三道五个月停经的患者例假正常；
治疗时间六个月反复发作的口腔溃疡、眼底黄斑渗出、各种顽固性皮肤病、三高症、痛风等等半年显效。
对于预防和治疗牙龈萎缩、牙周病效果也非常明显。

Claims (10)

1.本发明提供一种从细胞代谢这一根本问题着手，通过细胞障碍修复方法预防和治疗亚健康、亚临床的细胞障碍修复营养补充方法及其药物配方。本发明根据治疗不同阶段所需药剂有所不同，整个一个疗程分为三个阶段，使用三种不同配比的药剂，三种药剂分别命名为药剂A、药剂B、药剂C。
2.将肌苷、维他命C、维生素复合B、辅酶Q10、乐力钙、善存银片、硫辛酸、维生素E、维生素AD、叶酸、蜂胶、黄芪、甘草共13种药剂按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份；乐力钙：7.61份；善存银片：3.44份；硫辛酸：2.29份；维生素E：0.76份；维生素：AD0.61份；叶酸：0.03份；蜂胶：3.59份；黄芪：22.94份；甘草：22.94份，混合包装成小袋制成药剂A。
3.将肌苷、维他命C、维生素复合B、辅酶Q10共4种药剂按重量分配比分别为肌苷：4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份，混合包装成小袋制成药剂B。
4.将肌苷、维他命C、维生素复合B共3种药剂按重量分配比分别为肌苷4.59份；维他命C：2.29份；维生素复合B：1.38份；辅酶Q10：0.08份，混合包装成小袋制成药剂C。
5.其用法为：以30天为一个治疗疗程。
6.第1天到第10天，每天早上服用一袋药剂A，晚上服用一袋药剂B。
7.第11天到第20天，每天早晚各三袋药剂C。
8.第21天至30天，不吃药。
9.服用药剂A应随肉或蛋黄一起服用或服用前先食用一定量肉或蛋。
10.本发明能有效预防及治疗各类及慢性病，包括但不仅限于失眠、更年期综合症的潮热多汗、停经、口腔溃疡、眼底黄斑渗出、各种顽固性皮肤病、三高症、痛风、牙龈萎缩、牙周病。
CN201610975823.5A 2016-10-28 2016-10-28 一种细胞障碍修复营养补充方法及其药物配方 Pending CN106511447A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610975823.5A CN106511447A (zh) 2016-10-28 2016-10-28 一种细胞障碍修复营养补充方法及其药物配方

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610975823.5A CN106511447A (zh) 2016-10-28 2016-10-28 一种细胞障碍修复营养补充方法及其药物配方

Publications (1)

Publication Number Publication Date
CN106511447A true CN106511447A (zh) 2017-03-22

Family

ID=58350074

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610975823.5A Pending CN106511447A (zh) 2016-10-28 2016-10-28 一种细胞障碍修复营养补充方法及其药物配方

Country Status (1)

Country Link
CN (1) CN106511447A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111840295A (zh) * 2020-08-18 2020-10-30 隆琰 失眠治疗药物、制备方法及其在治疗失眠症上的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895671A (zh) * 2005-12-08 2007-01-17 淮北市辉克药业有限公司 治疗病毒型肝病的复方制剂
CN103766873A (zh) * 2012-10-22 2014-05-07 李文金 一种改善亚健康、抗衰老的组合物及其制剂

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895671A (zh) * 2005-12-08 2007-01-17 淮北市辉克药业有限公司 治疗病毒型肝病的复方制剂
CN103766873A (zh) * 2012-10-22 2014-05-07 李文金 一种改善亚健康、抗衰老的组合物及其制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111840295A (zh) * 2020-08-18 2020-10-30 隆琰 失眠治疗药物、制备方法及其在治疗失眠症上的应用

Similar Documents

Publication Publication Date Title
Lambert et al. Potential interaction between warfarin and boldo‐fenugreek
US20150056297A1 (en) Nutraceutical combination for prevention and treatment of type 2 diabetes
Amruthesh Dentistry and Ayurveda-IV: Classification and management of common oral diseases
CN102895472B (zh) 一种治疗口腔溃疡的外用组合药物及其制备方法
CN102727817A (zh) 一种治疗口腔溃疡的口服液
CN102258722A (zh) 一种治疗牙周炎的中药
US11596166B2 (en) Compositions and methods for treating aging and/or improving human health
CN106511447A (zh) 一种细胞障碍修复营养补充方法及其药物配方
CN102631373B (zh) 一种快速治疗口腔溃疡的药物香口胶
CN106668269A (zh) 一种治疗银屑病的外用中药
CN103417869A (zh) 一种治疗牙周炎的中药组合物
CN1231244C (zh) 一种滋补强身、延缓衰老的保健食品
CN101991829B (zh) 一种治疗胃病的药物
CN103638323B (zh) 治疗慢性萎缩性胃炎的中药丸剂
CN102488852B (zh) 一种祛痘组合物及其制备方法
JP2002238496A (ja) 医療保健食品
Parvizi et al. Olive in traditional Persian medicine: an overview
CN108420938B (zh) 一种能够修复、美白皮肤的中药组合物及其药剂制备方法
CN106389995A (zh) 一种抗衰老的组合物
CN102631522A (zh) 一种治疗儿童牙龈炎的药剂
Redfern Improving Acne, Eczema and Psoriasis in 30 Days: Clear Acne, Eczema and Psoriasis in 30 Days: Healthy Skin Rehabilitation For The Long Term
Rosenberg Electroacupuncture is beneficial in women with stress incontinence
CN100525790C (zh) 一种外用治疗复发性口腔溃疡的中药组合物
CN102784291B (zh) 一种治疗阴虚牙痛的外敷药物
CN100409876C (zh) 一种治疗口疮的药物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170322